Huntington's disease (HD) is an autosomal-dominant neurodegenerative disorder with no effective therapies. Mutant huntingtin protein (mHTT), the main HD proteinaceous hallmark, has been linked to reactive oxygen species (ROS) formation and mitochondrial dysfunction, among other pathological mechanisms. Importantly, Src-related kinases, c-Src and Fyn, are activated by ROS and regulate mitochondrial activity. However, c-Src/Fyn involvement in HD is largely unexplored. Thus, in this study, we aimed at exploring changes in Src/Fyn proteins in HD models and their role in defining altered mitochondrial function and dynamics and redox regulation.
Results:
We show, for the first time, that c-Src/Fyn phosphorylation/activation and proteins levels are decreased in several human and mouse HD models mainly due to autophagy degradation, concomitantly with mHtt-expressing cells showing enhanced TFEB-mediated autophagy induction and autophagy flux. c-Src/Fyn co-localization with mitochondria is also reduced. Importantly, the expression of constitutive active c-Src/Fyn to restore active Src kinase family (SKF) levels improves mitochondrial morphology and function, namely through improved mitochondrial transmembrane potential, mitochondrial basal respiration, and ATP production, but it did not affect mitophagy. In addition, constitutive active c-Src/Fyn expression diminishes the levels of reactive species in cells expressing mHTT.
Innovation:
This work supports a relevant role for c-Src/Fyn proteins in controlling mitochondrial function and redox regulation in HD, revealing a potential HD therapeutic target.
Conclusion:
c-Src/Fyn restoration in HD improves mitochondrial morphology and function, precluding the rise in oxidant species and cell death. Antioxid. Redox Signal. 38, 95–114.
Get full access to this article
View all access options for this article.
References
1.
ArachicheA, AugereauO, DecossasM, PertuisetC, GontierE, LetellierT, and Dachary-PrigentJ. Localization of PTP-1B, SHP-2, and Src exclusively in rat brain mitochondria and functional consequences. J Biol Chem, 283: 24406–24411, 2008.
2.
ChojnackaK and MrukDD. The Src non-receptor tyrosine kinase paradigm: new insights into mammalian Sertoli cell biology. Mol Cell Endocrinol, 415: 133–142, 2015.
3.
ChooYS. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum Mol Genet, 13: 1407–1420, 2004.
4.
DiFigliaM, SappE, ChaseKO, DaviesSW, BatesGP, VonsattelJP, and AroninN. Aggregation of Huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science (80-), 277: 1990–1993, 1997.
5.
FerreiraIL, CarmoC, NaiaL, MotaSI, and Cristina RegoA. Assessing mitochondrial function in in vitro and ex vivo models of Huntington's disease. Methods Mol Biol, 1780: 415–442, 2018.
HarrisKF, ShojiI, CooperEM, KumarS, OdaH, and HowleyPM. Ubiquitin-mediated degradation of active Src tyrosine kinase. Proc Natl Acad Sci U S A, 96: 13738–13743, 1999.
8.
HerbertAD, CarrAM, and HoffmannE. FindFoci: a focus detection algorithm with automated parameter training that closely matches human assignments, reduces human inconsistencies and increases speed of analysis. PLoS One, 9: e114749, 2014.
9.
IrtegunS, WoodRJ, OrmsbyAR, MulhernTD, and HattersDM. Tyrosine 416 is phosphorylated in the closed, repressed conformation of c-Src. PLoS One, 8: e71035, 2013.
10.
ItohS, LemayS, OsawaM, CheW, DuanY, TompkinsA, BrookesPS, SheuSS, and AbeJ. Mitochondrial Dok-4 recruits Src kinase and regulates NF-kappaB activation in endothelial cells. J Biol Chem, 280: 26383–26396, 2005.
11.
KazlauskaiteA, Martínez-TorresRJ, WilkieS, KumarA, PeltierJ, GonzalezA, JohnsonC, ZhangJ, HopeAG, PeggieM, TrostM, AaltenDM, AlessiDR, PrescottAR, KnebelA, WaldenH, and MuqitMM. Binding to serine 65-phosphorylated ubiquitin primes Parkin for optimal PINK 1-dependent phosphorylation and activation. EMBO Rep, 16: 939–954, 2015.
12.
KocEC, Miller-LeeJL, and KocH. Fyn kinase regulates translation in mammalian mitochondria. Biochim Biophys Acta Gen Subj, 1861: 533–540, 2017.
13.
KomatsuM, WaguriS, ChibaT, MurataS, IwataJ, TanidaI, UenoT, KoikeM, UchiyamaY, KominamiE, and TanakaK. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature, 441: 880–884, 2006.
14.
LiX-J and LiS. Proteasomal dysfunction in aging and Huntington disease. Neurobiol Dis, 43: 4–8, 2011.
15.
LivigniA, ScorzielloA, AgneseS, AdornettoA, CarlucciA, GarbiC, CastaldoI, AnnunziatoL, AvvedimentoEV, and FelicielloA. Mitochondrial AKAP121 Links cAMP and src signaling to oxidative metabolism. Mol Biol Cell, 17: 263–271, 2006.
16.
Martinez-VicenteM, TalloczyZ, WongE, TangG, KogaH, KaushikS, de VriesR, AriasE, HarrisS, SulzerD, and CuervoAM. Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease. Nat Neurosci, 13: 567–576, 2010.
17.
MorrealeMK. Huntington's disease: looking beyond the movement disorder. Adv Psychosom Med, 34: 135–142, 2015.
18.
NaiaL, CarmoC, CampesanS, FãoL, CottonVE, ValeroJ, LopesC, RosenstockTR, GiorginiF, and RegoAC. Mitochondrial SIRT3 confers neuroprotection in Huntington's disease by regulation of oxidative challenges and mitochondrial dynamics. Free Radic Biol Med, 163: 163–179, 2021.
19.
NaiaL and RegoAC. Isolation and maintenance of striatal neurons. Bio Protoc, 8: e2823, 2018.
20.
NapoliE, WongS, HungC, Ross-IntaC, BomdicaP, and GiuliviC. Defective mitochondrial disulfide relay system, altered mitochondrial morphology and function in Huntington's disease. Hum Mol Genet, 22: 989–1004, 2013.
21.
NarendraD, TanakaA, SuenDF, and YouleRJ. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol, 183: 795–803, 2008.
22.
OguraM, YamakiJ, HommaMK, and HommaY. Mitochondrial c-Src regulates cell survival through phosphorylation of respiratory chain components. Biochem J, 447: 281–289, 2012.
23.
OrrAL, LiS, WangC-E, LiH, WangJ, RongJ, XuX, MastroberardinoPG, GreenamyreJT, and LiX-J. N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J Neurosci, 28: 2783–2792, 2008.
24.
PandeyM, VargheseM, SindhuKM, SreetamaS, NavneetAK, MohanakumarKP, and UshaR. Mitochondrial NAD+-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington's disease. J Neurochem, 104: 420–434, 2008.
25.
PandeyUB, NieZ, BatleviY, McCrayBA, RitsonGP, NedelskyNB, SchwartzSL, DiProsperoNA, KnightMA, SchuldinerO, PadmanabhanR, HildM, BerryDL, GarzaD, HubbertCC, YaoT-P, BaehreckeEH, and TaylorJP. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature, 447: 860–864, 2007.
26.
ReddyPH and ShirendebUP. Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease. Biochim Biophys Acta Mol Basis Dis, 1822: 101–110, 2012.
27.
RibeiroM, RosenstockTR, OliveiraAM, OliveiraCR, and RegoAC. Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells. Free Radic Biol Med, 74: 129–144, 2014.
28.
RibeiroM, SilvaAC, RodriguesJ, NaiaL, and RegoAC. Oxidizing effects of exogenous stressors in Huntington's disease knock-in striatal cells—protective effect of cystamine and creatine. Toxicol Sci, 136: 487–499, 2013.
29.
RoskoskiR. Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors. Pharmacol Res, 94: 9–25, 2015.
30.
RossCA and TabriziSJ. Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol, 10: 83–98, 2011.
31.
SaftC, ZangeJ, AndrichJ, MüllerK, LindenbergK, LandwehrmeyerB, VorgerdM, KrausPH, PrzuntekH, and SchölsL. Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease. Mov Disord, 20: 674–679, 2005.
32.
SalviM, BrunatiAM, BordinL, La RoccaN, ClariG, and ToninelloA. Characterization and location of Src-dependent tyrosine phosphorylation in rat brain mitochondria. Biochim Biophys Acta, 1589: 181–195, 2002.
33.
SardanelliAM, SignorileA, NuzziR, De RasmoD, Technikova-DobrovaZ, DrahotaZ, OcchielloA, PicaA, and PapaS. Occurrence of A-kinase anchor protein and associated cAMP-dependent protein kinase in the inner compartment of mammalian mitochondria. FEBS Lett, 580: 5690–5696, 2006.
34.
SardielloM, PalmieriM, di RonzaA, MedinaDL, ValenzaM, GennarinoVA, Di MaltaC, DonaudyF, EmbrioneV, PolishchukRS, BanfiS, ParentiG, CattaneoE, and BallabioA. A gene network regulating lysosomal biogenesis and function. Science (80-), 325: 473–477, 2009.
35.
SettembreC, Di MaltaC, PolitoVA, Garcia ArencibiaM, VetriniF, ErdinS, ErdinSU, HuynhT, MedinaD, ColellaP, SardielloM, RubinszteinDC, and BallabioA. TFEB links autophagy to lysosomal biogenesis. Science, 332: 1429–1433, 2011.
36.
SettembreC, ZoncuR, MedinaDL, VetriniF, ErdinS, ErdinS, HuynhT, FerronM, KarsentyG, VellardMC, FacchinettiV, SabatiniDM, and BallabioA. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J, 31: 1095–1108, 2012.
37.
SieradzanKA and MannDM. The selective vulnerability of nerve cells in Huntington's disease. Neuropathol Appl Neurobiol, 27: 1–21, 2001.
38.
SilvaAC, AlmeidaS, LaçoM, DuarteAI, DominguesJ, OliveiraCR, JanuárioC, and RegoAC. Mitochondrial respiratory chain complex activity and bioenergetic alterations in human platelets derived from pre-symptomatic and symptomatic Huntington's disease carriers. Mitochondrion, 13: 801–809, 2013.
39.
SlowEJ. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet, 12: 1555–1567, 2003.
40.
SongC, ZhangY, ParsonsCG, and LiuYF. Expression of polyglutamine-expanded huntingtin induces tyrosine phosphorylation of N-methyl-d-aspartate receptors. J Biol Chem, 278: 33364–33369, 2003.
41.
SunN, MalideD, LiuJ, RoviraII, CombsCA, and FinkelT. A fluorescence-based imaging method to measure in vitro and in vivo mitophagy using mt-Keima. Nat Protoc, 12: 1576–1587, 2017.
42.
TrettelF. Dominant phenotypes produced by the HD mutation in STHdhQ111 striatal cells. Hum Mol Genet, 9: 2799–2809, 2000.
43.
TwigG and ShirihaiOS. The interplay between mitochondrial dynamics and mitophagy. Antioxidants Redox Signal, 14: 1939–1951, 2011.
44.
WangY, BotvinickEL, ZhaoY, BernsMW, UsamiS, TsienRY, and ChienS. Visualizing the mechanical activation of Src. Nature, 434: 1040–1045, 2005.
45.
YanoH, BaranovSV, BaranovaOV, KimJ, PanY, YablonskaS, CarlisleDL, FerranteRJ, KimAH, and FriedlanderRM. Inhibition of mitochondrial protein import by mutant huntingtin. Nat Neurosci, 17: 822–831, 2014.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
